You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

List of Excipients in API omaveloxolone

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing omaveloxolone

Subscribe to access the full database, or Get Started Free
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Biogen	SKYCLARYS	omaveloxolone	64406-250	CELLULOSE, MICROCRYSTALLINE	2030-02-28
Biogen	SKYCLARYS	omaveloxolone	64406-250	CROSCARMELLOSE SODIUM	2030-02-28
Biogen	SKYCLARYS	omaveloxolone	64406-250	FD&C BLUE NO. 1	2030-02-28
Biogen	SKYCLARYS	omaveloxolone	64406-250	FERRIC OXIDE YELLOW	2030-02-28
Biogen	SKYCLARYS	omaveloxolone	64406-250	HYPROMELLOSES	2030-02-28
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for omaveloxolone

Excipient focus: CELLULOSE, MICROCRYSTALLINE

omaveloxolone drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Biogen	omaveloxolone	64406-250
Reata Pharmaceuticals Inc	omaveloxolone	73179-250
>Company	>Ingredient	>NDC

omaveloxolone drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSCARMELLOSE SODIUM

omaveloxolone drug variants containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Biogen	omaveloxolone	64406-250
Reata Pharmaceuticals Inc	omaveloxolone	73179-250
>Company	>Ingredient	>NDC

omaveloxolone drug variants not containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FD&C BLUE NO. 1

omaveloxolone drug variants containing FD&C BLUE NO. 1

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Biogen	omaveloxolone	64406-250
Reata Pharmaceuticals Inc	omaveloxolone	73179-250
>Company	>Ingredient	>NDC

omaveloxolone drug variants not containing FD&C BLUE NO. 1

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE YELLOW

omaveloxolone drug variants containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Biogen	omaveloxolone	64406-250
Reata Pharmaceuticals Inc	omaveloxolone	73179-250
>Company	>Ingredient	>NDC

omaveloxolone drug variants not containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE

omaveloxolone drug variants containing HYPROMELLOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Reata Pharmaceuticals Inc	omaveloxolone	73179-250
>Company	>Ingredient	>NDC

omaveloxolone drug variants not containing HYPROMELLOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Biogen	omaveloxolone	64406-250
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSES

omaveloxolone drug variants containing HYPROMELLOSES

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Biogen	omaveloxolone	64406-250
>Company	>Ingredient	>NDC

omaveloxolone drug variants not containing HYPROMELLOSES

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Reata Pharmaceuticals Inc	omaveloxolone	73179-250
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

omaveloxolone drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Biogen	omaveloxolone	64406-250
Reata Pharmaceuticals Inc	omaveloxolone	73179-250
>Company	>Ingredient	>NDC

omaveloxolone drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: STARCH, CORN

omaveloxolone drug variants containing STARCH, CORN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Reata Pharmaceuticals Inc	omaveloxolone	73179-250
>Company	>Ingredient	>NDC

omaveloxolone drug variants not containing STARCH, CORN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Biogen	omaveloxolone	64406-250
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

omaveloxolone drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Biogen	omaveloxolone	64406-250
Reata Pharmaceuticals Inc	omaveloxolone	73179-250
>Company	>Ingredient	>NDC

omaveloxolone drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.